Follow this preprint
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
Marcelo Silva, Andrés Espejo, María L Pereyra, Martín Lynch, Marcos Thompson, Hernán Taconelli, Patricia Baré, Matías J Pereson, Marcelo Garbini, Pablo Crucci, Diego Enriquez
doi: https://doi.org/10.1101/2021.03.03.21252509
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Marcelo Silva
1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
Andrés Espejo
1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
María L Pereyra
1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
Martín Lynch
1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
Marcos Thompson
1Unidad de Hepatología y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
Hernán Taconelli
2Sanatorio Nuestra Señora del Pilar, Ciudadela, Argentina
Patricia Baré
3IIHEMA, IMEX-CONICET, Academia Nacional de Medicina
Matías J Pereson
3IIHEMA, IMEX-CONICET, Academia Nacional de Medicina
Marcelo Garbini
4Departamento de Investigación Clínica, Laboratorios Roemmers
Pablo Crucci
4Departamento de Investigación Clínica, Laboratorios Roemmers
Diego Enriquez
4Departamento de Investigación Clínica, Laboratorios Roemmers

Data Availability
All data referred to in the manuscript is available upon request
Posted March 05, 2021.
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
Marcelo Silva, Andrés Espejo, María L Pereyra, Martín Lynch, Marcos Thompson, Hernán Taconelli, Patricia Baré, Matías J Pereson, Marcelo Garbini, Pablo Crucci, Diego Enriquez
medRxiv 2021.03.03.21252509; doi: https://doi.org/10.1101/2021.03.03.21252509
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3045)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (849)
- Genetic and Genomic Medicine (4778)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3031)
- Health Policy (1097)
- Hematology (405)
- HIV/AIDS (953)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (492)
- Neurology (4549)
- Nursing (243)
- Nutrition (672)
- Oncology (2366)
- Ophthalmology (667)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (297)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7140)
- Radiology and Imaging (1588)
- Respiratory Medicine (941)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (506)
- Toxicology (63)
- Transplantation (218)
- Urology (187)